(NCNA) – Hot Corp. News
-
NuCana (NCNA) Phase 3 Biliary Tract Cancer Study is Being Discontinued
-
NuCana (NCNA) Reports Promising Clinical Data at ASCO GI on NUC-1031 as Front-Line Treatment of Advanced Biliary Tract Cancer
-
-
Back to NCNA Stock Lookup